Answers are grounded in this paper and cite their sources.
Case report demonstrates severe hyperlipidemia in a patient with IgA-kappa multiple myeloma, highlighting the rare role of M protein in elevating circulating lipid levels.
Key Clinical MessageIn the majority of cases, patients with multiple myeloma (MM) generally exhibit normal or decreased blood lipid levels.However, a minority of cases demonstrate the significant role of M protein in elevated lipid levels, particularly in the close association between IgA type MM and hypertriglyceridemia and hypercholesterolemia. Here, we report a case of IgA-κ type MM with concurrent hyperlipidemia, wherein the patient presented with elevated lipid levels upon admission: total cholesterol of 10.44 mmol/L (normal range: 2.8-5.6 mmol/L) and triglycerides of 28.45 mmol/L (normal range: 0.45-1.70mmol/L).The patient also had concurrent multiple myeloma and was treated with the PCD regimen along with lipid-lowering measures, hydration, alkalization, liver protection, and symptomatic supportive care, who showed a significant improvement in symptoms and was discharged.This report discusses a case treated at the Second Affiliated Hospital of Henan University of Science and Technology, retrospectively summarizing and analyzing the patient's data, and, in conjunction with relevant literature, explores the relationship between IgA type MM and hyperlipidemia.The aim is to provide guidance for clinical diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: